Spark Therapeutics (ONCE) Tops Q4 EPS by 49c

Spark Therapeutics (NASDAQ: ONCE) reported Q4 EPS of ($0.24), $0.49 better than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Spark Therapeutics (ONCE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Genco rejects Diana Shipping takeover bid as undervalued